000 | 01976 a2200577 4500 | ||
---|---|---|---|
005 | 20250515132638.0 | ||
264 | 0 | _c20090112 | |
008 | 200901s 0 0 eng d | ||
022 | _a1432-0584 | ||
024 | 7 |
_a10.1007/s00277-008-0571-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCamera, Andrea | |
245 | 0 | 0 |
_aSequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. _h[electronic resource] |
260 |
_bAnnals of hematology _cFeb 2009 |
||
300 |
_a151-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aSalvage Therapy |
650 | 0 | 4 | _aStem Cell Transplantation |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
700 | 1 | _aRinaldi, Ciro R | |
700 | 1 | _aPalmieri, Salvatore | |
700 | 1 | _aCantore, Nicola | |
700 | 1 | _aMele, Giuseppina | |
700 | 1 | _aMettivier, Vincenzo | |
700 | 1 | _aMiraglia, Eustachio | |
700 | 1 | _aMastrullo, Lucia | |
700 | 1 | _aGrimaldi, Francesco | |
700 | 1 | _aLuciano, Luigia | |
700 | 1 | _aGuerriero, Anna | |
700 | 1 | _aRotoli, Bruno | |
700 | 1 | _aFerrara, Felicetto | |
773 | 0 |
_tAnnals of hematology _gvol. 88 _gno. 2 _gp. 151-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-008-0571-z _zAvailable from publisher's website |
999 |
_c18182118 _d18182118 |